In murine experiments, metforminhas been shown to impede early AAA progression by modulating AMPK activity,decreasing the production of interferon-gamma-expressing T cells, and enhancingthe retention of circulating and splenic inflammatory monocytes [32]. Here, IFNG is linked to triple-A syndrome.